IOVA   $8.54  3.64% Market Closed After Close 8.61 0.82%

Iovance Biotherapeutics Inc
Total Cash 412.54M
totalCashPerShare 1.359
EBITDA -439.25M
Total Debt 81.68M
quickRatio 4.743
currentRatio 5.15
Total Revenue 32.77M
debtToEquity 10.628
Revenue/Share 0.124
ROA -0.33345002
ROE -0.65357
grossProfits
freeCashflow -221.83M
operatingCashflow -388.76M
earningsGrowth
revenueGrowth 129.697
grossMargins -0.44434
ebitdaMargins 0.0
operatingMargins -3.27635
profitMargins 0.0
enterpriseValue 3.21B
forwardPE -15.855264
floatShares 224.39M
sharesOutstanding 303.51M
sharesShort 60.34M
sharesShortPriorMonth 60.29M
dateShortInterest
sharesPercentSharesOut 0.20%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.88%
Short Ratio help_outline 14.23%
shortPercentOfFloat 0.22%
impliedSharesOutstanding
bookValue 2.585
Price To Book help_outline 4.66
earningsQuarterlyGrowth
netIncomeToCommon -440.22M
trailingEps -1.67%
forwardEps -0.76%
enterpriseToEbitda -7.30
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.3 3Q 2024
institutionsCount 392
lastUpdated Nov. 6, 2024, 6:29 p.m.